Center for Drug Evaluation and Research

From Wikipedia, the free encyclopedia

The Center for Drug Evaluation and Research is a division of the FDA that deals with the approval of drugs. CDER reviews New Drug Applications to ensure that the drugs are safe and effective.

The CDER receives considerable public scrutiny, and thus implements processes that tend toward objectivity and tend to isolate decisions from being attributed to specific individuals. In keeping with this, reviews are generally staffed by teams that are intended to come to consensus on decisions.

Within the CDER "Review teams" employs around 1,300 employees to approve new drugs. Additionally, the CDER employs a "safety team" has 72 employees to determine whether new drugs are unsafe or present risks not disclosed in the product's labeling.

The FDA's budget for approving, labeling, and monitoring drugs is roughly $290 million per year. The safety team monitors the effects of more than 3,000 prescription drugs on 200 million people with a budget of about $15 million a year. The FDA requires a four phased series of clinical trials, with phase three being the largest and usually requiring 1,000-3,000 patients.

The current Acting Director is Dr. Steven Galson.

CDER submits requests for advice to many different Advisory Committees. These committees, composed of experts in their respective fields, provide non-binding advice to CDER about the advisability of approving particular drugs.

There are sixteen advisory committees functioning within CDER:

  • Anesthetic and Life Support Drugs
  • Anti-Infective Drugs
  • Antiviral Drugs
  • Arthritis Drugs
  • Cardiovascular and Renal Drugs
  • Dermatologic and Ophthalmic Drugs
  • Drug Safety and Risk Management
  • Endocrinologic and Metabolic Drugs
  • Gastrointestinal Drugs
  • Nonprescription Drugs
  • Onologic Drugs, also known as the Oncology Drug Advisory Committee
  • Peripheral and Central Nervous System Drugs
  • Pharmaceutical Science and Clinical Pharmacology
  • Psychopharmacologic Drugs
  • Pulmonary-Allergy Drugs
  • Reproductive Health Drugs

[1]

 This United States government-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../c/e/n/Center_for_Drug_Evaluation_and_Research_4f06.html"
Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.